Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.37 USD | +0.77% | +0.88% | +58.64% |
Financials (USD)
Sales 2024 * | 1B | Sales 2025 * | 1.17B | Capitalization | 744M |
---|---|---|---|---|---|
Net income 2024 * | 13M | Net income 2025 * | 29M | EV / Sales 2024 * | 0.97 x |
Net Debt 2024 * | 233M | Net Debt 2025 * | 463M | EV / Sales 2025 * | 1.04 x |
P/E ratio 2024 * |
55.7
x | P/E ratio 2025 * |
25.7
x | Employees | 1,920 |
Yield 2024 * |
2.61% | Yield 2025 * |
2.58% | Free-Float | 49.9% |
Latest transcript on Phibro Animal Health Corporation
1 day | +0.77% | ||
1 week | +0.88% | ||
Current month | +10.00% | ||
1 month | +38.12% | ||
3 months | +46.61% | ||
6 months | +79.39% | ||
Current year | +58.64% |
Managers | Title | Age | Since |
---|---|---|---|
Jack Bendheim
CEO | Chief Executive Officer | 77 | 68-12-31 |
Glenn David
DFI | Director of Finance/CFO | 52 | Feb. 08 |
Larry Miller
COO | Chief Operating Officer | 60 | 08-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jack Bendheim
CEO | Chief Executive Officer | 77 | 68-12-31 |
E. Corcoran
BRD | Director/Board Member | 77 | 08-04-30 |
Carol Wrenn
BRD | Director/Board Member | 63 | 10-06-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.33% | 25 M€ | -1.64% | - | |
0.32% | 28 M€ | -0.73% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-21 | 18.37 | +0.77% | 101,730 |
24-05-20 | 18.23 | -0.92% | 108,624 |
24-05-17 | 18.4 | +2.34% | 194,317 |
24-05-16 | 17.98 | -1.48% | 101,517 |
24-05-15 | 18.25 | +0.22% | 148,299 |
Delayed Quote Nasdaq, May 21, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+58.64% | 738M | |
-12.45% | 79.57B | |
+12.08% | 8.4B | |
+25.88% | 3.76B | |
-0.14% | 3.18B | |
+14.19% | 1.67B | |
+0.56% | 1.64B | |
-17.79% | 1.38B | |
-0.39% | 1.32B | |
-5.20% | 1.24B |
- Stock Market
- Equities
- PAHC Stock